TheJobsMapUnleash Immuno Oncolytics jobs and careers
St. Louis, MO, United States
As of October 24, 2026, Unleash Immuno Oncolytics has no open roles listed.
About Unleash Immuno Oncolytics
Unleash IO develops oncolytic immunotherapy products shown to be highly specific and efficacious in animal models and human tissue samples. Unleash IO’s leading product, UIO-512, is an oncolytic adenovirus that targets both malignant cells and tumor-associated stroma cells.
Founded in 2015 by David T. Curiel.
- Founded
- 2015
- Employees
- 1 to 10
- Total funding
- $3M
- Headquarters
- St. Louis
Leadership
The top of Unleash Immuno Oncolytics's org chart, with how many people report into each leader.
DK
Daniel Katzman
CEO & Founder
1 report
IK
Imre (Imi) Kovesdi
Chief Scientific Officer
Jobs at Unleash Immuno Oncolytics
No open positions right now. Explore more companies on TheJobsMap.
Unleash Immuno Oncolytics jobs: common questions
- Is Unleash Immuno Oncolytics hiring right now?
- Unleash Immuno Oncolytics has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Unleash Immuno Oncolytics's careers site.
- Where is Unleash Immuno Oncolytics headquartered?
- Unleash Immuno Oncolytics is headquartered in St. Louis, MO, United States and was founded in 2015.
- Who leads Unleash Immuno Oncolytics?
- Daniel Katzman, CEO & Founder, is at the top of Unleash Immuno Oncolytics's org chart.
- How do I apply for a job at Unleash Immuno Oncolytics?
- Pick a role on Unleash Immuno Oncolytics's TheJobsMap page and select Apply. Every listing links to the original posting on Unleash Immuno Oncolytics's own careers site, so you apply directly with the employer.